MedTrace Logo

The Effect of Growth Hormone Replacement on Liver Fat

NCT00774579 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-07-12

Study results available
· View outcomes & findings →

Summary

We will examine a cohort of growth hormone deficient adults starting growth hormone (GH) replacement. The purpose of this study is to determine whether GH replacement reduces the fat content of the liver.

To compare the results we will include growth hormone deficient patients who do not start GH replacement as controls.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Fabian A Meienberg, Dr · Imperial College London

  • Stephen Robinson, Dr · Imperial College London

  • Jeremy Cox, Dr · Imperial College London

  • Ian Godsland, Dr · Imperial College London

  • Jimmy Bell, Dr · Imperial College London

  • Desmond G Johnston, Prof · Imperial College London

  • Simon Taylor-Robinson, Prof · Imperial College London

  • Emma Hatfield, Dr · Imperial College London

  • Michael Yee, Dr · Imperial College London

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-03-31
Completion
2009-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00774579 on ClinicalTrials.gov